Company intelligence / Profile preview

GlycoMatrix

Dublin, California, USA

Ownership: Private
Employees: ~5
Development stage: Other

Overview

GlycoMatrix is a biotechnology company specializing in the development and manufacture of high-quality glycobiology reagents. The company's primary focus is on lectins, lectin conjugates, and carbohydrate-binding proteins used in research and diagnostic applications. Their product portfolio supports researchers in fields such as oncology, immunology, and cell biology by providing tools for glycan analysis and cell surface characterization. GlycoMatrix offers a wide range of purified lectins, including those conjugated to fluorophores, biotin, and enzymes, as well as customized glycobiology solutions.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: ProteinRecombinant protein
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on GlycoMatrix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GlycoMatrix.

Explore the full profile